Antibody Production Market is expected to generate a revenue of USD 9.28 Billion by 2030, Globally, at 13.14% CAGR: Verified Market Research
The increased demand for monoclonal and polyclonal antibodies, increased R&D expenditure by pharmaceutical and biotechnological companies, to stay ahead of the competition and to find innovative